Alcohol and Hepatocellular Carcinoma
Clinics in Liver Disease · 2024-11 · 28 (4) · 633-646
DOI: 10.1016/j.cld.2024.06.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2024-11. Verfasst von Nghiem B Ha und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hepatology, Liver Transplant, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, 505 Parna…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
Abstract (Originalsprache)
Alcohol-associated liver disease (ALD) poses a significant risk for hepatocellular carcinoma (HCC), comprising various liver conditions from steatosis to cirrhosis. Despite accounting for a third of global HCC cases and deaths, ALD-related HCC lacks characterization compared to viral hepatitis-related HCC. Proposed mechanisms for ALD-related HCC include acetaldehyde toxicity, increased reactive oxygen species, and inflammation. This review examines ALD-associated HCC epidemiology, co-factors like viral hepatitis and metabolic syndrome, surveillance, and treatment challenges. Despite advances in screening and management, ALD-related HCC often presents at advanced stages, limiting treatment options and survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hepatology, Liver Transplant, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, 505 Parnassus Avenue, S-357, San Francisco, CA 94112, USA.
- Hepatology, Liver Transplant, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, 505 Parnassus Avenue, S-357, San Francisco, CA 94112, USA. Electronic address:…
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
Zitieren
APA
Ha, N. B., & Yao, F. (2024). Alcohol and Hepatocellular Carcinoma. Clinics in Liver Disease, 28(4), 633-646. https://doi.org/10.1016/j.cld.2024.06.007
Vancouver
Ha NB, Yao F. Alcohol and Hepatocellular Carcinoma. Clinics in Liver Disease. 2024;28(4):633-646. doi:10.1016/j.cld.2024.06.007
BibTeX
@article{Ha2024,
author = {Ha, Nghiem B and Yao, Francis},
title = {Alcohol and Hepatocellular Carcinoma},
journal = {Clinics in Liver Disease},
year = {2024},
volume = {28},
number = {4},
pages = {633--646},
doi = {10.1016/j.cld.2024.06.007}
}
EUVIMED